Genome Editing

Selected news for the healthcare topic - Genome Editing, collected since 10/2017. Recent stories appear in translations-news.com. This healthcare topic shares news with CRISPR, Precision BioSciences, LogicBio Therapeutics, Gene Therapy, Intellia Therapeutics and over a hundred others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
6/24/2021 Penn Medicine developing next generation of viral vectors for genome editing - PhillyVoice.com translations-news.com Penn Medicine developing next generation of viral vectors for genome editing PhillyVoice.com In May, Penn announced a gene therapy alliance with Biogen, the oldest biotechnology company in the United States, aimed at advancing gene therapy research and gene editing technologies. The collaboration, potentially worth up to $2 billion for the ...
6/23/2021 Penn Medicine developing next generation of viral vectors for genome editing - PhillyVoice.com translations-news.com Penn Medicine developing next generation of viral vectors for genome editing PhillyVoice.com In May, Penn announced a gene therapy alliance with Biogen, the oldest biotechnology company in the United States, aimed at advancing gene therapy research and gene editing technologies. The collaboration, potentially worth up to $2 billion for the ...
6/23/2021 Penn Medicine developing next generation of viral vectors for genome editing - PhillyVoice.com translations-news.com Penn Medicine developing next generation of viral vectors for genome editing PhillyVoice.com In May, Penn announced a gene therapy alliance with Biogen, the oldest biotechnology company in the United States, aimed at advancing gene therapy research and gene editing technologies. The collaboration, potentially worth up to $2 billion for the ...
6/23/2021 Penn Medicine developing next generation of viral vectors for genome editing - PhillyVoice.com translations-news.com Penn Medicine developing next generation of viral vectors for genome editing PhillyVoice.com In May, Penn announced a gene therapy alliance with Biogen, the oldest biotechnology company in the United States, aimed at advancing gene therapy research and gene editing technologies. The collaboration, potentially worth up to $2 billion for the ...
6/23/2021 Penn Medicine developing next generation of viral vectors for genome editing - PhillyVoice.com translations-news.com Penn Medicine developing next generation of viral vectors for genome editing PhillyVoice.com In May, Penn announced a gene therapy alliance with Biogen, the oldest biotechnology company in the United States, aimed at advancing gene therapy research and gene editing technologies. The collaboration, potentially worth up to $2 billion for the ...
6/23/2021 Genome Editing Market Insights Covering Market Dynamics and Competitive Scenario through 2025 picayunecurrent.com Genome Editing Market Insights Covering Market Dynamics and Competitive Scenario through 2025 By Tweet on Twitter Global Genome Editing  Market – Drivers, Restraints, Opportunities, Trends, and Forecast, 2019–2025 [98 pages report] This market research report includes a detailed segmentation of the global genome editing market – by technology (CRISPR, TALEN, ZFN, and Others), by application (Cell Line Engineering, Genetic Engineering, and Others), By end ...
6/21/2021 Reviewing LogicBio Therapeutics (NASDAQ:LOGC) & CASI Pharmaceuticals (NASDAQ:CASI) thelincolnianonline.com ... insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.LogicBio Therapeutics Company ProfileLogicBio Therapeutics, Inc., a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is designed to integrate corrective genes into a patient's genome to provide ...